Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 45.60 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 55.50 | Oscillator | Neutral |
| Williams %R (14) | -38.83 | Oscillator | Neutral |
| MACD (12, 26, 9) | -2.42 (Hist 0.40) | Oscillator | Buy |
| Average Directional Index (14) | 18.98 (+DI 20.7 / -DI 28.2) | Trend | Neutral |
| EMA 20 | 142.78 | MA | Sell |
| SMA 20 | 142.78 | MA | Sell |
| EMA 50 | 148.79 | MA | Strong Sell |
| SMA 50 | 146.54 | MA | Strong Sell |
| SMA 200 | 170.49 | MA | Strong Sell |
Current price $141.17
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 16, 26 | BMO Capital | maintain | Market Perform | Market Perform |
| Oct 7, 26 | Truist Securities | maintain | Buy | Buy |
| Oct 6, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Oct 5, 26 | JP Morgan | maintain | Overweight | Overweight |
| Sep 8, 26 | Citigroup | upgrade | Neutral | Buy |
| Aug 11, 26 | Bernstein | maintain | Market Perform | Market Perform |
| Jul 31, 26 | Stifel | maintain | Buy | Buy |
| Jul 31, 26 | Citigroup | maintain | Neutral | Neutral |
| Jul 30, 26 | TD Cowen | maintain | Hold | Hold |
TTM vs. 5-year historical average (annual ratios)
| Metric | CHRW | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 26.6x | 24.0x · sector 18.4x | Elevated |
| Forward P/E (FY26E) | 22.4x | EPS est. 6.31 | Discount |
| Price / Book | 10.3x | 8.1x | Elevated |
| Price / Sales | 1.0x | 0.7x | Elevated |
| EV / EBITDA | 18.3x | 17.0x | In line |
| Return on equity | 36.0% | — | Top tier |
| Gross margin | 10.1% | 7.4% | Above hist. |
| Debt / Equity | 1.21 | 1.22 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 7.53 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 425 | Oct 9, 2026 | 2026-10-09 06:02:07 | View |
| 425 | Oct 6, 2026 | 2026-10-06 17:25:28 | View |
| 425 | Oct 6, 2026 | 2026-10-06 17:15:05 | View |
| 425 | Oct 6, 2026 | 2026-10-05 21:35:30 | View |
| 425 | Oct 6, 2026 | 2026-10-05 18:03:47 | View |
| 425 | Oct 6, 2026 | 2026-10-05 18:02:02 | View |
| 425 | Oct 6, 2026 | 2026-10-05 17:54:03 | View |
| 425 | Oct 5, 2026 | 2026-10-05 17:26:11 | View |
| 425 | Oct 5, 2026 | 2026-10-05 17:22:09 | View |
| 425 | Oct 5, 2026 | 2026-10-05 17:11:14 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 30, 26 | Gokey Timothy C | director | A-Award | 208 | — |
| Sep 30, 26 | Goodburn Mark A. | director | A-Award | 246 | — |
| Jul 8, 26 | Lee Damon J. | officer: Chief Financial Officer | F-InKind | 4,698 @ $190.95 | $897.1K |
| Jun 30, 26 | Goodburn Mark A. | director | A-Award | 193 | — |
| Jun 30, 26 | Gokey Timothy C | director | A-Award | 163 | — |
| Jun 26, 26 | Bozeman David P | director, officer: President & CEO | F-InKind | 11,693 @ $180.34 | $2.11M |
| May 29, 26 | Rajan Arun | officer: Chief Strat & Innov Officer | A-Award | 8,714 | — |
| May 7, 26 | Tolliver Paula | director | A-Award | 992 | — |
Stock news · updated daily
CHRW heads into Q3 2026 earnings with expectations of double-digit growth, but rising truckload costs and margin pressures may weigh on results.
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 1.53 | 1.61 | Beat 5.2% | $4.93B |
| Apr 29, 2026 | 1.23 | 1.35 | Beat 9.8% | $4.01B |
| Jan 28, 2026 | 1.12 | 1.23 | Beat 9.8% | $3.91B |
| Oct 29, 2025 | 1.30 | 1.40 | Beat 7.7% | $4.14B |
| Jul 30, 2025 | 1.16 | 1.29 | Beat 11.2% | $4.14B |
| Apr 30, 2025 | 1.05 | 1.17 | Beat 11.4% | $4.05B |